MIRA
INFORM REPORT
|
Report Date : |
16.10.2008 |
IDENTIFICATION
DETAILS
|
Name : |
SRI RAGHAVENDRA BIOTECHNOLOGIES PRIVATE LIMITED |
|
|
|
|
Registered Office : |
1/ 17, Indraprashta Samata Nagar, Kandivali (East), Mumbai – 400 101,
Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
27.01.2000 |
|
|
|
|
Com. Reg. No.: |
123875 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U85100MH2000PTC123875 |
|
|
|
|
IEC No.: |
0303044004 |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAECS9854R |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of Business : |
Providing Research, Training and Consultancy Services. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 2500 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established company having satisfactory track. Trade
relations are fair. Business is steady. Payments are usually correct and as
per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
INFORMATION PARTED
BY
|
Name : |
Mr. Venkatesh |
|
Designation : |
Manager |
|
Contact No.: |
Mobile no. 91-9845450473 |
|
Date : |
07.10.2008 |
LOCATIONS
|
Registered Office : |
1/ 17, Indraprashta Samata Nagar, Kandivali (East), Mumbai – 400 101,
Maharashtra, India. |
|
Mobile No.: |
91-9845450473 (Mr. Venkatesh) |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
800 sq ft |
|
Location : |
Owned |
|
|
|
|
Laboratory : |
# 117, Venkateshwaranagar, Near Sampige Halli, Jakkur Post, Yelahanka,
Bangalore – 560 064, Karnataka, India. |
|
Tel. No.: |
91-80-65652220/ 28462175 |
|
Mobile No.: |
91-9845475321 / 9845450473 / 9900645271 |
|
Fax No.: |
91-80-28462175 |
|
Area : |
2000 sq ft |
|
Location : |
Owned |
DIRECTORS
|
Name : |
Mr. Shreemushnam Gopalkrishna Ananda Rao |
|
Designation : |
Director |
|
Address : |
1/ 17, Indraprashta Samata Nagar, Kandivali (East), Mumbai – 400 101,
Maharashtra, India. |
|
Date of Birth/Age : |
09.04.1941 |
|
Qualification : |
P.H.D. |
|
Date of Appointment : |
07.11.2002 |
|
|
|
|
Name : |
Mrs. Jyothsna Ananda Rao |
|
Designation : |
Director |
|
Address : |
1/ 17, Indraprashta Samata Nagar, Kandivali (East), Mumbai – 400 101,
Maharashtra, India. |
|
Date of Birth/Age : |
13.05.1967 |
|
Qualification : |
P.H.D. |
|
Date of Appointment : |
27.01.2000 |
|
|
|
|
Name : |
Mrs. Sunanda Ananda Rao |
|
Designation : |
Director |
|
Address : |
1/ 17, Indraprashta Samata Nagar, Kandivali (East), Mumbai – 400 101,
Maharashtra, India. |
|
Date of Birth/Age : |
27.09.1944 |
|
Qualification : |
M. Sc. |
|
Tel. No. : |
91-22-8873030/ 8872503 |
|
Date of Appointment : |
27.01.2000 |
|
|
|
|
Name : |
Mr. Gururaj Anand Rao |
|
Designation : |
Director |
|
Address : |
1/ 17, Indraprashta Samata Nagar, Kandivali (East), Mumbai – 400 101,
Maharashtra, India. |
|
Date of Birth/Age : |
12.09.1974 |
|
Date of Appointment : |
27.01.2000 |
KEY EXECUTIVES
|
Name : |
Mr. Venkatesh |
|
Designation : |
Manager |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
As on 30.09.2004
|
Names of Shareholders |
No. of Shares |
|
Mrs. Sunanda Anand Rao |
4010 |
|
Mr. Gururaj Anand Rao |
10010 |
|
Mr. Shree Mushnam Gopal Krishna Anand Rao |
7000 |
|
Mrs. Jyothsna Anand Rao |
4000 |
|
Genevieve Vaz |
100 |
|
Winnie M.P. Fennarvoes |
100 |
|
Sretve Fennarvoes |
100 |
|
|
|
|
Total |
25320 |
As on 26.09.2007
Equity share breakup (percentage of total equity)
|
Category |
Percentage |
|
Directors or relatives of directors |
98.82 |
|
Other top 50 shareholders |
1.18 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Providing Research, Training and Consultancy Services. |
|
|
|
|
Exports : |
|
|
Countries : |
U.S. |
|
|
|
|
Terms : |
|
|
Selling : |
Credit 30 days |
|
|
|
|
Purchasing : |
Cash and Credit 30 days |
GENERAL
INFORMATION
|
Customers : |
|
|
|
|
|
No. of Employees : |
6 |
|
|
|
|
Bankers : |
Canara Bank, Hebbal Branch, Bangalore |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
Pereira and Subramanian Chartered Accountants |
|
Address : |
D/ 207, Shiv Ashish Cosmo CHS. Limited, Plot No.66, S.V. Road, Andheri
(West), Mumbai – 400 058, Maharashtra, India. |
|
|
|
|
Associates/Subsidiaries : |
Cryostemcell Private Limited |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
50000 |
Equity Shares |
Rs.10/- Each |
Rs.0.500 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
25320 |
Equity Shares |
Rs.10/- Each |
Rs.0.253
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are in Rupees Millions]
|
Particulars |
|
|
31.03.2008 |
|
Service Revenue (Estimated) |
|
|
1.000 |
|
|
|
|
|
Expected Service Revenue (2008-09): Above Rs.1.000 Millions
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
0.253 |
0.253 |
0.253 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
0.240 |
0.049 |
0.000 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
(0.007) |
|
|
NETWORTH |
0.493 |
0.302 |
0.246 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
0.968 |
0.753 |
0.545 |
|
|
TOTAL BORROWING |
0.968 |
0.753 |
0.545 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
1.461 |
1.055 |
0.791 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
1.501 |
1.029 |
0.524 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.025 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
0.004
|
0.016 |
0.022 |
|
|
Sundry Debtors |
0.000
|
0.000 |
0.000 |
|
|
Cash & Bank Balances |
0.438
|
0.304 |
0.012 |
|
|
Other Current Assets |
0.051
|
0.037 |
0.032 |
|
|
Loans & Advances |
0.194
|
0.263 |
0.200 |
|
Total
Current Assets |
0.687
|
0.620 |
0.266 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
0.685
|
0.553 |
0.032 |
|
|
Provisions |
0.047
|
0.047 |
0.000 |
|
Total
Current Liabilities |
0.732
|
0.600 |
0.032 |
|
|
Net Current Assets |
(0.045)
|
0.020 |
0.234 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.005 |
0.006 |
0.008 |
|
|
|
|
|
|
|
|
TOTAL |
1.461 |
1.055 |
0.791 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
|
|
Service Revenue |
|
2.356 |
1.425 |
|
|
Other Income |
|
0.000 |
0.000 |
|
|
Total Income |
|
2.356 |
1.425 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
0.223 |
0.092 |
|
|
Provision for Taxation |
|
-- |
-- |
|
|
Profit/(Loss) After Tax |
|
0.223 |
0.092 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Interest |
|
0.010 |
0.011 |
|
|
Depreciation & Amortization |
|
0.266 |
0.085 |
|
|
Other Expenditure |
|
1.857 |
1.237 |
|
Total Expenditure |
|
2.133 |
1.333 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
PAT / Total Income |
(%) |
9.47
|
6.46 |
NA |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
9.47
|
6.46 |
NA |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
10.19
|
5.58 |
NA |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.45
|
0.30 |
NA |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
3.45
|
4.48 |
2.35 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
0.94
|
1.03 |
8.31 |
LOCAL AGENCY
FURTHER INFORMATION
|
Additional
Requirement of Indiamart for Trust-Seal |
|
|
|
|
|
IEC Code : 0303044004 |
|
|
|
|
|
PAN / TAN : AAECS9854R |
|
|
|
|
|
Bank Name : Canara Bank |
|
|
Bank Address : , Hebbal, Bangalore |
|
|
Bank A/c. No.:1206 |
|
|
Account Since :4 Years
|
|
TRADE REFERENCES:
- Jain
Institute of Vascular Sciences, Bangalore
- Frontier,
Chennai
WEBSITE DETAILS
PROFILE:
Subject was incepted in the year of 2000 as
an organization which provides various research and consultancy services for stem
cells. With the backing of the services, they strive to establish a number of
applications in stem cell based therapeutics. In the year of 2003, they
inaugurated a laboratory with a cGMP regulated "Clean Room" facility.
They are consistently providing stem cell banking technology to the established
Cryo Stem cell (Karnataka) Private Limited for last 5 years. This training is
aimed towards life science students in stem cell biology, animal cell culture,
and drug screening by the “Invitro” method.
The company has also signed MOU’s for the collaboration in R&D arena with
numerous reputed research institutions. They offer their services to various
clinics, hospitals and students. For the outstation students, they have
arrangements for local accommodation also.
SERVICES:
- Student
Training Program
- Short
Term Projects in Biotechnology
- Short
Term Workshop
- Biological
Laboratory Projects
- Stem
Cell Research
- Stem
Cell Based Clinical Application
- Stem
Cell Laboratory Consultancy
- Stem
Cell Technology Product Development
- Stem
Cells Banking
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.43 |
|
UK Pound |
1 |
Rs.84.54 |
|
Euro |
1 |
Rs.65.91 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|